The global burden of fungal disease varies substantially by country and by locality within country, as well as by risk group. To gain a full picture of the incidence and prevalence of fungal diseases, as well as trends over time, local, regional and national studies are critical.
In addition to estimating the burden of fungal diseases by country (see published papers here) and 60 country abstracts here:
Abstracts: Iran, Mongolia, Zambia, Korea, Jamaica, Trinidad & Tobago, Dominican Republic, Guatemala, Sri Lanka
Abstracts: Austria, Brazil, China, India, India, Ireland, Israel, Kenya, Netherlands, Nigeria, Senegal, Singapore, Spain, Uganda.
Abstracts: Argentina, Australia, Belgium,Mexico, Saudi Arabia, Tanzania
ECCMID, ISHAM and API 2015
Abstracts: Nepal, Thailand, Canada, Ecuador, Chile, Jordan, Egypt, Indonesia, New Zealand
Abstracts: Czech Republic, Denmark, Hungary, Germany, UK, Iraq, Ukraine, Veitnam
AAA 7th and ECCMID 2016
Abstracts: Japan, Bangladesh, Malaysia, Peru, Congo
Abstracts: Algeria, France, Greece, Madagascar, Mozambique, Pakistan, Portugal, Serbia, Venezuela
GAFFI is promoting several epidemiological studies. These include:
- Chronic pulmonary aspergillosis after TB
- Uganda (completed)
- Cryptococcal pneumonia
- Histoplasma skin test prevalence